India’s Lupin Acquires Europe-Based VISUfarma to Expand Specialty…

Sarah J · 2026-04-02T17:23:14.000Z

Lupin Limited has completed the acquisition of VISUfarma, marking a major step in its strategy to expand its specialty pharmaceutical business and deepen its presence across Europe. The deal, executed through its Netherlands-based subsidiary, brings a well-established ophthalmology platform into Lupin’s global portfolio. The acquisition significantly enhances Lupin’s capabilities in eye care, adding more than 60 branded products spanning key therapeutic areas such as dry eye, glaucoma, retinal health, and eyelid disorders. This expansion positions the company to tap into the rapidly growing global ophthalmology market, driven by ageing populations and rising cases of diabetes-related eye conditions. VISUfarma’s strong commercial footprint across major European markets- including Italy, the United Kingdom, Germany, Spain, and France- provides Lupin with immediate scale and market access. The company also brings an experienced team and established relationships with healthcare providers, strengthening Lupin’s ability to deliver specialized treatments and expand its reach in high-value segments. Strategically, the acquisition aligns with Lupin’s long-term vision of building a differentiated specialty care portfolio beyond generics. By integrating VISUfarma’s infrastructure and product range, Lupin is not only diversifying its revenue streams but also accelerating the development of its global specialty franchise, particularly in Europe. The move reflects a broader trend in the pharmaceutical industry, where companies are increasingly investing in niche therapeutic areas and regional platforms to drive sustainable growth. For Lupin, this acquisition represents a transition toward higher-value, innovation-driven segments, strengthening its competitive positioning in international markets. As demand for advanced eye care solutions continues to rise globally, Lupin’s expanded ophthalmology portfolio and enhanced European presence are expected to play a key role in shaping its next phase of growth.

Member Login Get Access

India’s Lupin Acquires Europe-Based VISUfarma to Expand Specialty… | SEINET